Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Immunoblastic Lymphadenopathy × Paclitaxel × Clear all

Sponsor

Conditions

Breast Neoplasms 167 Carcinoma, Non-Small-Cell Lung 140 Ovarian Neoplasms 80 Lung Neoplasms 50 Fallopian Tube Neoplasms 49 Neoplasms 44 Triple Negative Breast Neoplasms 33 Neoplasm Metastasis 28 Carcinoma, Ovarian Epithelial 21 Parkinson Disease 4, Autosomal Dominant Lewy Body 20 Esophageal Neoplasms 20 Stomach Neoplasms 18 Squamous Cell Carcinoma of Head and Neck 18 Head and Neck Neoplasms 18 Adenocarcinoma of Lung 16 Endometrial Neoplasms 14 Breast Neoplasms, Male 14 Urinary Bladder Neoplasms 12 Melanoma 12 Carcinoma 12 Recurrence 11 Uterine Cervical Neoplasms 10 Brenner Tumor 10 Adenocarcinoma Of Esophagus 10 Carcinoma, Squamous Cell 9 Prostatic Neoplasms 8 Peritoneal Neoplasms 8 Esophageal Squamous Cell Carcinoma 8 Adenocarcinoma, Bronchiolo-Alveolar 8 Small Cell Lung Carcinoma 7

Interventions

fludarabine phosphate 14 Cyclophosphamide 13 Whole-Body Irradiation 11 Peripheral Blood Stem Cell Transplantation 11 Etoposide 10 Tacrolimus 9 Mycophenolic Acid 7 Rituximab 6 Methotrexate 6 Melphalan 6 Cyclosporine 6 Busulfan 6 Antilymphocyte Serum 6 Vorinostat 4 Sirolimus 4 Prednisone 4 Lenalidomide 4 Immunohistochemistry 4 Gene Expression Profiling 4 Carboplatin 4 Vincristine 3 Microarray Analysis 3 Everolimus 3 Doxorubicin 3 Dexamethasone 3 Alemtuzumab 3 thymoglobulin 2 prednylidene 2 fludarabine 2 etoposide phosphate 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡